Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Energy drink company. The new CEO has been quite clear in the press releases that Cen Biotech (and bill chanaan) are no longer a part of this company. I assumed all the volume last week was people thinking this company had a chance do make it in the energy drink business, if people still thought last week FITX was still in pursuit of the MJ business well those people don't take the time to read the stuff the company is putting out.
GLTA
LOL, I'll take a glass of your house merlot, please. Don't want to count my chickens before they hatch.
Maybe a little less Merlot and lot more reading?
This is from the PR that was released by the company yesterday morning @ 9:30am est.
"Medicated Markets delegation will depart Toronto at the end of current week, January 18th 2015 with Easton Pharmaceuticals hoping to announce a finalized agreement between the two parties; at that point or shortly thereafter."
So you decide if there is a PR looming.
GLTA
Same bold posts for the year I've been here. Over, and over, and over and over..... you get the point. He's mod and ends them with imo, but be prepared for your and my posts to be deleted, off message.
GLTY
FY2014 Filing will be Audited. Not necessary to file FY2013 retroactively. The company is an open book relatively speaking for an OTC stock. It's all out there to be read by intersted parties, if you have additional questions send the company an e-mail, they always respond to my e-mails.
GLTA
Current News: Easton Pharmaceuticals Finalizes and Forwards Its 2013 Audited Financials to an Existing Medical Marihuana Acquisition Target and a Health Canada Medical Marijuana for Medical Purposes (MMPR) Applicant
TORONTO, ON--(Marketwired - Dec 1, 2014) - Easton Pharmaceuticals Inc. (OTC: EAPH) announces it has arranged to have its completed 2013 audit to be handed over to two American and Canadian based Medical Marihuana Growers whom the company has had ongoing communications with. As previously stated, grower details are expected to be disclosed within the second week of December as per allowances made on due diligence documentation and agreements.
Easton Pharmaceuticals Finalizes and Forwards Its 2013 Audited Financials to an Existing Medical Marihuana Acquisition Target and a Health Canada Medical Marijuana for Medical Purposes (MMPR) Applicant
TORONTO, ON--(Marketwired - Dec 1, 2014) - Easton Pharmaceuticals Inc. (OTC: EAPH) announces it has arranged to have its completed 2013 audit to be handed over to two American and Canadian based Medical Marihuana Growers whom the company has had ongoing communications with. As previously stated, grower details are expected to be disclosed within the second week of December as per allowances made on due diligence documentation and agreements.
Couldn't agree more! In other news Easton has completed it's 2013 Audited financials by November 30th as stated by the company, and reiterates financing is all lined up once HC gets their head out of their a$$.
GLTA
As did many other penny stocks. Can you say INDEPENDENT, ACCREDITED 2013 AUDITED NUMBERS BY END OF NOVEMBER, AND INDEPENDENT, ACCREDITED 2014 NUMBERS TO FOLLOW?
Not too concerned about a late filing with this Audit going on, rather wait for the audited numbers to I don't have to read nonsense on message boards.
GLTA
EAPH has an agreement to purchase 49% ownership in a company awaiting
final inspection from health Canada. They also have deal in place to finance the
Purchase of the 49% ownership. Just waiting for health Canada and everything else
is lined up and ready to go.
Both. Can't have a seller without a buyer and can't have a buyer without a seller.
I'm sure the average investor knows the difference between Authorized shares and Outstanding shares, but for the record LATF has 10b Authorized shares and 5.2B outstanding shares.
Still a ton of shares outstanding, to be sure.
GLTA
What I've learned is that IHub is not a website for free exchange of information, thoughts, or ideas. People become moderators with agendas and as long as your opinions and ideas are in line with theirs, post till your blue in the face. If on the other hand your have the opposite opinions, your posts simply get deleted. There is no recourse you can send e-mails to IHub admins, nothing is done.
As a result it get's quiet.
JMO
You know it's not good times when the only post in 4 hours is an insightful quote from Warren Buffet.
jmo
I didn't say FITX, someone else did. I was not referring to FITX, last a checked FITX is a Company based in Michigan not in Canada as my message said.
I was thinking about a company with 1/7th of the O/S as that of FITX. I see "if" and "when" in the PR just like this other companies PR's. Again, if you have a horse in the game with this one good for you, if you don't have a horse in the game for the other one, not need to write article and slow it's momentum, right?
So let me try and understand this. One Canadian company with a possible deal with a company that's waiting for a site inspection and zero revenues is a good investment, but another Canadian company that has a possible deal with a company waiting for a site inspection and zero revenues (and has more cash on hand I'll add) is a bad investment?
Maybe is was the 20:1 reverse split last September that MDCN did excited you? Or do you just pump the stocks you own and dump on the ones you don't own?
Funny man!
jmo
Balance sheet insolvency involves having negative net assets—where liabilities exceed assets.
If anyone wants to take 2 minutes they will find that at the end of Q1 2014 EAPH reported Net Assets of $626,000 Dollars, hardly insolvent, next.
JMO
EAPH MMJ Deals:
Easton Pharmaceuticals Inc. announces that as per updates it has received, site facility build-out as mandated per health Canada MMPR guidelines are near completion and soon ready for the scheduling of a new inspection on MMJ property where Easton holds exclusive option to purchase up to 50% ownership interest in private MMPR medical marijuana grower located in Ontario, Canada.
Easton Pharmaceuticals will be decided upon within the next week to 10 days which involves two proposals and investment opportunities in the medical marijuana industry. The first proposal stems from a signed LOI and discussions initiated with UMED Health and Wellness Centers located in the State of Michigan, current owners of an operating medical marijuana dispensary since January of this year. The discussions with UMED involve terms based around Easton Pharmaceuticals opening one or possibly more medical marijuana dispensary(s) in the State of Michigan with UMED being the manager of the operating business and facility. A counter proposal has been submitted to UMED where both companies would form a 50/50 joint partnership for new dispensaries with Easton paying the fees and expenses required to open the facilities and UMED finding the locations, design, launch the facilities, locate the product and patients for the dispensary.
Easton Pharmaceuticals Announces New Non-Dilutional Financing Source to Be Utilized Towards Its Medical Marijuana Initiative and Acquisitions
Easton Pharmaceuticals Announces New Non-Dilutional Financing Source to Be Utilized Towards Its Medical Marijuana Initiative and Acquisitions
EAPH MMJ Deals:
Easton Pharmaceuticals Inc. announces that as per updates it has received, site facility build-out as mandated per health Canada MMPR guidelines are near completion and soon ready for the scheduling of a new inspection on MMJ property where Easton holds exclusive option to purchase up to 50% ownership interest in private MMPR medical marijuana grower located in Ontario, Canada.
Easton Pharmaceuticals will be decided upon within the next week to 10 days which involves two proposals and investment opportunities in the medical marijuana industry. The first proposal stems from a signed LOI and discussions initiated with UMED Health and Wellness Centers located in the State of Michigan, current owners of an operating medical marijuana dispensary since January of this year. The discussions with UMED involve terms based around Easton Pharmaceuticals opening one or possibly more medical marijuana dispensary(s) in the State of Michigan with UMED being the manager of the operating business and facility. A counter proposal has been submitted to UMED where both companies would form a 50/50 joint partnership for new dispensaries with Easton paying the fees and expenses required to open the facilities and UMED finding the locations, design, launch the facilities, locate the product and patients for the dispensary.
Potential Revenue:
" Easton Pharmaceuticals recently announced its agreement to invest and acquire an ownership interest in AMFIL Technologies Inc. and the mPACT-Grozone Antimicrobial Systems Line of Products. The Grozone product line, which includes the mPACT 60 unit, can be customized to fit the needs of small, medium and large medical marijuana growing facilities as well as other types of industries and applications. Once the unit's efficacy is validated at one location, the necessity for additional integrated units throughout the cultivation areas should be secured."
Potential Revenue:
"Easton Pharmaceuticals Inc. announces that as per updates it has received, site facility build-out as mandated per health Canada MMPR guidelines are near completion and soon ready for the scheduling of a new inspection on MMJ property where Easton holds exclusive option to purchase up to 50% ownership interest in private MMPR medical marijuana grower located in Ontario, Canada."
Potential Revenue:
"A counter proposal has been submitted to UMED where both companies would form a 50/50 joint partnership for new dispensaries with Easton paying the fees and expenses required to open the facilities and UMED finding the locations, design, launch the facilities, locate the product and patients for the dispensary. Discussions have also involved a direct investment into UMED for expansion of their existing business which after 6 months of operations with their own dispensary, revenues according to UMED are projected to conservatively reach $1 Million at the current pace with cumulative increases projected over the next few years."
Potential Revenue:
"As previously disclosed, Easton has engaged and announced that BMV Medica S.A. de C.V. has been appointed as its sole exclusive distributor in Mexico. BMV has signed an agreement with Easton on utilizing its resources and relationships aimed at marketing Viorra successfully in a market that BMV believes can be positioned as a leading-edge daily-use woman's health product to also assist in the treatment of FSAD type conditions. Easton has given BMV its approval to launch certain initiatives once manufacturing has been set up in Mexico, currently being addressed by BMV, which when complete, could also supply the United States, Canadian and International markets."
When will D. Bagi, Carla Pepe, Mellon, and Adams be hailed as hero's for rasing $5 million cash and firmly rooting EAPH in the $1.3Billion dollar MMJ market in Canada?
jmo
EAPH O/S = 498 million
EAPH UP 1100% in 2014!
What is known, is that the O/S are 500 million. On June 4th the Company said they had secured a 5 million dollar non dilutional investment which "Should Easton choose this financing option it would greatly reduce its dependence on its REG. A financing which was recently filed with the Securities and Exchange Commission and is awaiting any comments."
If you know otherwise, please post that information and it's origin. Thanks.
500 Million O/S shares is hardly a share selling machine compared to other MJ companies with billions of shares O/S.
IMO
EAPH up 566% YTD
GLTA
I HAVE E-MAILED EAPH AT LEAST HALF DOZEN TIMES AND RECEIVED A TIMELY REPLY EVERY TIME.
glta
I HAVE PERSONALLY E-MAILED EASTON PHARMA AT LEAST HALF DOZEN TIMES AND RECEIVED A MESSAGE BACK FROM THEM EVERY TIME!
GLTA
That quieted some people down!
You look again.
"Where did this juicy revenue figure come from, considering FITX still hasn’t launched its grow op facility in Lakeshore, Canada? The answer is further down the report. The company described selling a 7.5% interest in the net revenue interest of its facility against the sum of $5 million. This was just a fraction of the 25% revenue interest FITX intends to sell for a total of $20 million.
What’s a little strange in this instance is that the company recorded the $5 million under revenues, even though this does not constitute operating or ‘regular’ revenue. Who bought the 7.5% interest is also not known."
JMO
Comparison, FITX $0 Revenues, Market Cap $200million vs EAPH $0 Revenues and Market Cap 10million
My point PPS is not associated today on existing revenues, rather it is associated with perceived potential revenues in the future whether they come to fruition in either companies case is rolling the dice.
JMO
.40 cent PPS = FITX Market Cap!
Then why tell the world a PR will happen on Wednesday and then Wednesday morning tell the world a PR is coming on Thursday and then on Friday say nothing and still no PR? This behavior has been going on for so long, I can no longer find it in myself to excuse this behavior. It's border line criminal at this point.
A good laugh, because if you can't laugh at the incredible inability of this company to provide a PR when they say they are, you'll go crazy with frustration.
One guy tweeted EAPH this, after their tweet today.
"It's gone out for review?Email, traditional mail or carrier pigeon it out? I'm guessing it's option # 3. About 2-3 weeks?"
NOW THAT'S FUNNY!
Hard for me to imagine that a Company and its' leadership would orchestrate a scenario where they have lost all credibility in the market? No one can any longer believe anything they say, right? I'm leaning towards incompetence or lack of business acumen.
NO DILUTION people if you want to know what is going on you have to do a little leg work. DO NOT SIMPLY BELIEVE POSTS ON HERE ARE VALID
Here is a msg the company sent me one week ago.
"The Reg. A does not have a set price. it depends on the average trading price and not a set price. It is not yet approved and no shares have yet been issued. The outstanding shares are a tad under 500 million and none have been issued for 2 Months."
So unless someone wants to say that the people bold face lied, there has been no diliution in two months!
Have you ever heard the story of the boy who cried wolf to many times? EAPH has said many times in the past over many months now that they were a whisker hair from a deal in the MM industry. I guess people just no longer believe them? I'll wait for the actual news, evaluate, and see how the market values the deal. Tough lesson for the leadership of this company, but you simply cannot lead the public on; as well as, your investors on over and over and over.....